BeiGene

Express | BeiGene released its 2022 first quarter financial report, what are the expected milestones?
BeiGene Bai Yue Ze Bai Zean btk has ks公司 zanidatamab 倍利妥 Amgen Corporation 帕米帕利
05-07
And Huang and Xinda folded, what kind of innovative pharmaceutical companies are easier to go to sea
Pharmaceutical companies Innovative medicine 胡会国 BeiGene Zebutinib
05-03
Industry Watch | Advancing Global Health with Sustainable Innovation BeiGene releases 2021 ESG Report
BeiGene ESG reports esg
04-29
Industry Watch | Advancing Global Health with Sustainable Innovation BeiGene Releases 2021 ESG Report
BeiGene ESG reports esg
04-29
Biomedical Observation No. 29 | Legendary Biology successfully broke through Europe and the United States, and domestic innovative drugs went to sea to welcome milestones
Biomedicine Legendary creatures BeiGene Cinda Bio
04-18
BTK battle, BeiGene took the lead in reaching the "global finals"
BeiGene btk Ibltinib Pharmaceutical companies Zebutinib
04-13
A number of drugs were approved in one day, including 3 important anti-cancer drugs
Indications Terelizumab anticancer Non-small cell lung cancer Tocilizumab Ensatinib pd-1 BeiGene
04-13
Why hillhouse reduced its holdings in Hengrui
Hillhouse Reduction Hengrui Hengrui Pharmaceutical shareholder BeiGene
03-24
The Responses of BeiGene and Zaiding Pharma were added to the SEC's Tentative List
U.S. Securities and Exchange Commission Zaiding Medicine BeiGene Foreign Company Accountability Act Foreign Company Accountability Act Accounting firm
03-12
Are Chinese stocks stable? From entering the "scheduled delisting list" to "consultation is smoother"
Chinese stocks U.S. Securities and Exchange Commission and Huang Medicine BeiGene Hong Kong
03-11
Chinese stocks have exploded again! How many discounts have been made in stocks over the past year?
Chinese stocks Zaiding Medicine and Huang Medicine U.S. Securities and Exchange Commission BeiGene
03-11
The financial reports of pharmaceutical companies have flowed out one after another: some people have made 10 billion yuan, and some people have fallen into the whirlpool of losses
Pharmaceutical companies Earnings BeiGene Covid vaccine Coronavirus
03-03
Executive Compensation Leaderboard Announced! With an annual salary of 100 million, who is the strongest "hit worker"?
Salary Xpeng Motors Gu Hongdi BeiGene Tencent Internet enterprises JD Liu Qiangdong No cheng jianhua
02-17
BeiGene's dilemma: the chief R&D has been replaced twice in three years; the book loss is 2.7 billion
BeiGene loss Listed Be brave
02-15
Application for marketing authorization for new indications of Zebutinib in BeiGene was accepted
BeiGene Bai Yue Ze Zebutinib Small lymphocytic lymphoma Fahrenheit macroglobulinemia Chronic lymphocytic leukemia
01-29
Global layout brings differentiated advantages BeiGene's entire industrial chain capabilities are gradually complete
BeiGene Terelizumab Industrial chain Zebutinib cll
01-26
In 2021, the cooperation between innovative pharmaceutical companies BD reached a new high, and the IPO ideas of pharmaceutical companies may be reversed in the future
Pharmaceutical companies ipo BeiGene CStone Pharmaceuticals
01-24
Breaking through the dilemma of multiple myeloma recurrence, BeiGene introduced new drugs to open supply in China
Multiple myeloma BeiGene Carlos
01-06
In 2021, 83 new drugs were approved, and Roche and BeiGene ranked first in the number of approvals
BeiGene Indications National Health Insurance Pharmaceutical companies
01-04
A Vision for the New Year of Medicine People
AstraZeneca Executive Vice President Wang Lei Cinda Bio BeiGene
01-04